CN117964712A - Qin prophage, novel variant of protein YnfQ and method for producing L-aromatic amino acid using the same - Google Patents
Qin prophage, novel variant of protein YnfQ and method for producing L-aromatic amino acid using the same Download PDFInfo
- Publication number
- CN117964712A CN117964712A CN202311384058.6A CN202311384058A CN117964712A CN 117964712 A CN117964712 A CN 117964712A CN 202311384058 A CN202311384058 A CN 202311384058A CN 117964712 A CN117964712 A CN 117964712A
- Authority
- CN
- China
- Prior art keywords
- protein
- amino acid
- ynfq
- corynebacterium
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101710098372 Protein YnfQ Proteins 0.000 title claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- 229940024606 amino acid Drugs 0.000 claims abstract description 48
- 150000001413 amino acids Chemical class 0.000 claims abstract description 35
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 22
- 229960005190 phenylalanine Drugs 0.000 claims abstract description 12
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 11
- 229960004441 tyrosine Drugs 0.000 claims abstract description 6
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 241000186216 Corynebacterium Species 0.000 claims description 30
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 21
- 108091033319 polynucleotide Proteins 0.000 claims description 13
- 102000040430 polynucleotide Human genes 0.000 claims description 13
- 239000002157 polynucleotide Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 241000588722 Escherichia Species 0.000 claims description 10
- 239000004474 valine Substances 0.000 claims description 6
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- 244000005700 microbiome Species 0.000 abstract description 10
- 238000006467 substitution reaction Methods 0.000 abstract description 5
- 230000004952 protein activity Effects 0.000 abstract description 2
- 235000001014 amino acid Nutrition 0.000 description 42
- 108090000623 proteins and genes Proteins 0.000 description 40
- 239000013598 vector Substances 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 25
- 239000002609 medium Substances 0.000 description 25
- 235000018102 proteins Nutrition 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 21
- 241000588724 Escherichia coli Species 0.000 description 19
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 19
- 230000014509 gene expression Effects 0.000 description 14
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 229930027917 kanamycin Natural products 0.000 description 11
- 229960000318 kanamycin Drugs 0.000 description 11
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 11
- 229930182823 kanamycin A Natural products 0.000 description 11
- 239000012634 fragment Substances 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 101100544656 Escherichia coli (strain K12) ynfQ gene Proteins 0.000 description 9
- 101100544659 Escherichia coli (strain K12) ynfT gene Proteins 0.000 description 9
- 230000010076 replication Effects 0.000 description 9
- 230000035772 mutation Effects 0.000 description 8
- 229960004799 tryptophan Drugs 0.000 description 8
- 229960000723 ampicillin Drugs 0.000 description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- -1 aromatic amino acids Chemical class 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 108020005004 Guide RNA Proteins 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 210000001236 prokaryotic cell Anatomy 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 2
- 241001014386 Corynebacterium canis Species 0.000 description 2
- 241001134763 Corynebacterium flavescens Species 0.000 description 2
- 241000186226 Corynebacterium glutamicum Species 0.000 description 2
- 241000158523 Corynebacterium striatum Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 238000012366 Fed-batch cultivation Methods 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241000588717 Shimwellia blattae Species 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000012365 batch cultivation Methods 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000588732 Atlantibacter hermannii Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- 241000186248 Corynebacterium callunae Species 0.000 description 1
- 241000644075 Corynebacterium caspium Species 0.000 description 1
- 241001605246 Corynebacterium crudilactis Species 0.000 description 1
- 241000446654 Corynebacterium deserti Species 0.000 description 1
- 241000272936 Corynebacterium doosanense Species 0.000 description 1
- 241001644925 Corynebacterium efficiens Species 0.000 description 1
- 241000521406 Corynebacterium freiburgense Species 0.000 description 1
- 241000291063 Corynebacterium halotolerans Species 0.000 description 1
- 241000015585 Corynebacterium humireducens Species 0.000 description 1
- 241000024402 Corynebacterium imitans Species 0.000 description 1
- 241000095130 Corynebacterium lubricantis Species 0.000 description 1
- 241000778959 Corynebacterium marinum Species 0.000 description 1
- 241000128247 Corynebacterium pollutisoli Species 0.000 description 1
- 241000186246 Corynebacterium renale Species 0.000 description 1
- 241000334675 Corynebacterium singulare Species 0.000 description 1
- 241001098119 Corynebacterium spheniscorum Species 0.000 description 1
- 241000186308 Corynebacterium stationis Species 0.000 description 1
- 241000960580 Corynebacterium testudinoris Species 0.000 description 1
- 241000737368 Corynebacterium uterequi Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241001240954 Escherichia albertii Species 0.000 description 1
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 1
- 241000588720 Escherichia fergusonii Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000219470 Mirabilis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000588733 Pseudescherichia vulneris Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 101100221606 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) COS7 gene Proteins 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013601 cosmid vector Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 101150066743 ynfQ gene Proteins 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to a novel variant of Qin prophage or protein YnfQ and a method for producing an L-aromatic amino acid using the same, wherein the variant of Qin prophage or protein YnfQ is modified in protein activity by substitution of one or more amino acids constituting the amino acid sequence of Qin prophage or protein YnfQ, and thus L-tryptophan, L-phenylalanine or L-tyrosine can be efficiently produced by a recombinant microorganism comprising the variant.
Description
Technical Field
The present invention relates to Qin prophage, novel variants of protein YnfQ and methods for producing L-aromatic amino acids using the same.
Background
Amino acids are classified into hydrophobic, hydrophilic, basic and acidic amino acids according to the nature of side chains, and amino acids having benzene rings therein are called aromatic amino acids. Among the aromatic amino acids, phenylalanine, tyrosine and tryptophan are essential amino acids that cannot be synthesized in living bodies, and belong to the high value-added industry that forms a market of $3000 million each year worldwide.
The production of aromatic amino acids can be carried out using wild-type strains obtained in a natural state or variant strains modified in such a manner as to enhance the amino acid productivity. In recent years, in order to improve the production efficiency of aromatic amino acids, genetic recombination techniques have been applied to microorganisms such as E.coli and coryneform bacteria which are used in many cases for producing useful substances such as L-amino acids, and various recombinant strains or variants having excellent L-aromatic amino acid productivity have been developed, and a method for producing L-aromatic amino acids using the same. In particular, the following attempts were made: the production of the corresponding amino acid is increased by targeting genes such as enzymes, transcription factors, transport proteins, etc. involved in the biosynthesis pathway of the L-aromatic amino acid, or inducing mutation in promoters regulating their expression. However, since the types of proteins such as enzymes, transcription factors, transport proteins, etc., which are directly or indirectly involved in the production of L-aromatic amino acids, are several tens of kinds, a great deal of research is actually required as to whether the L-aromatic amino acid production capacity is increased or not according to the activity change of such proteins.
Prior art literature
Patent literature
Korean patent No. 10-1830002
Disclosure of Invention
The present invention aims at providing novel Qin prophage, variants of protein YnfQ.
In addition, it is an object of the present invention to provide polynucleotides encoding the above variants.
In addition, it is an object of the present invention to provide a transformant comprising the above variant or polynucleotide.
The present invention also provides a method for producing an L-aromatic amino acid using the transformant.
In one embodiment of the present invention, there is provided a variant of Qin prophage or protein YnfQ comprising the amino acid sequence of SEQ ID No. 4, wherein aspartic acid (Asp) No. 26 in the amino acid sequence of SEQ ID No. 2 is replaced with valine (Val).
As used herein, "Qin prophage, protein YnfQ (Qin prophage; protein YnfQ)" is part of a Qin prophage and is expressed by induction of cold shock (cold shock) expression. In the present invention, the Qin prophage and the protein YnfQ may be a polypeptide encoded by ynfQ gene and having the activity of Qin prophage and protein YnfQ, but are not limited thereto.
The sequence information of the Qin prophage, nucleic acid of the protein YnfQ and protein can be obtained from a well-known sequence database (e.g., genBank, uniProt).
According to one embodiment of the present invention, the Qin prophage and the protein YnfQ may be encoded by the base sequence of SEQ ID No. 1 or may be constituted by the amino acid sequence of SEQ ID No. 2.
The amino acid sequence of Qin prophage, protein YnfQ or the base sequence encoding it according to the invention may comprise a base sequence or amino acid sequence having at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% homology or identity to the respective sequence. The term "homology" or "identity" as used herein refers to the percentage of identity (%) between two sequences when the base sequence or amino acid sequence to be used as a reference is aligned with any other base sequence or amino acid sequence so as to correspond to the maximum extent for analysis.
According to one embodiment of the invention, the Qin prophage, the variant of the protein YnfQ or the gene encoding it may be derived from wild type escherichia coli (ESCHERICHIA COLI).
As used herein, "variant" refers to a polypeptide in which one or more amino acids at the N-terminal, C-terminal and/or within the amino acid sequence of a particular gene are conservatively substituted (conservative substitution), deleted (modified), altered (modified) or added to differ from the amino acid sequence prior to mutation, but maintain functions or properties. As used herein, "conservative substitutions" refer to the substitution of one amino acid for another that is structurally and/or chemically similar, with little or no effect on the activity of the protein or polypeptide. The amino acid is selected from alanine (Ala), isoleucine (Ile), valine (Val), leucine (Leu), methionine (Met), asparagine (Asn), cysteine (Cys), glutamine (Gln), serine (Ser), threonine (Thr), phenylalanine (Phe), tryptophan (Trp), tyrosine (Tyr), aspartic acid (Asp), glutamic acid (Glu), arginine (Arg), histidine (His), lysine (Lys), glycine (Gly) and proline (Pro).
In addition, variants include variants with more than one N-terminal leader sequence or a portion of the transmembrane domain (transmembrane domain) removed, or variants with a portion of the N-and/or C-terminal of the mature protein (protein) removed.
Such variants may have increased (enhanced), or unchanged, or decreased (attenuated) capacity compared to the protein prior to mutation. Herein, "adding or enhancing" includes the following cases: the activity of the protein itself is increased as compared with the protein before mutation; in the case where the overall intracellular enzyme activity level is high compared with that of the wild-type strain or the strain expressing the protein before mutation due to increased expression or increased translation of the gene encoding the protein, etc.; and combinations thereof. Furthermore, "reducing or weakening" includes the following: the activity of the protein itself is reduced as compared with the protein before mutation; the expression of a gene encoding a protein is inhibited, translation is inhibited, or the like, so that the overall intracellular enzymatic activity is lower than that of the wild-type strain or the strain expressing the protein before mutation; and combinations thereof. In the present invention, variants may be used in combination with variants, alterations, variant polypeptides, variant proteins, variants, and the like.
A variant of a Qin prophage, a protein YnfQ according to the invention may comprise an amino acid sequence having at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% homology or identity to the amino acid sequence of SEQ ID NO. 4. Such protein variants may be included without limitation as long as the amino acid sequence maintains the function or property of each protein variant.
Another aspect of the invention provides a polynucleotide encoding a variant of the Qin prophage, protein YnfQ described above.
The "polynucleotide (polynucleotide)" used in the present invention is a polymer (polymer) of nucleotides in which nucleotide monomers (monomers) are linked in a chain-like manner by covalent bonds, and is a DNA or RNA strand of a predetermined length or more, more specifically, a polynucleotide fragment encoding the Qin prophage or protein YnfQ variant.
The above polynucleotide contains a base sequence encoding the amino acid sequence of SEQ ID NO. 4, for example, may contain a base sequence of SEQ ID NO. 3.
Another embodiment of the present invention provides a vector comprising a polynucleotide encoding a variant of the Qin prophage, protein YnfQ described above.
In addition, another embodiment of the present invention provides a transformant comprising the Qin prophage, a variant of protein YnfQ, or a polynucleotide as described above.
The term "vector" as used herein refers to any type of nucleic acid sequence transport structure used as a means for delivering and expressing a target gene into a host cell. Unless otherwise indicated, such vectors may refer to the insertion of a supported nucleic acid sequence into a host cell gene for expression and/or expression separately. Such vectors include the necessary regulatory elements operably linked for expression of the gene insert, "operably linked (operably linked)" means that the gene of interest and its regulatory sequences are functionally bound to each other and linked in a manner that enables gene expression, "regulatory elements" include promoters for carrying out transcription, any operator sequences for regulating transcription, sequences encoding suitable mRNA ribosome binding sites, and sequences that regulate termination of transcription and translation.
The vector used in the present invention is not particularly limited as long as it can replicate in a host cell, and any vector known in the art can be used. Examples of the vector include plasmids, cosmids, viruses, and phages in their natural or recombinant state. For example, as phage vectors or cosmid vectors, we15, M13, λmbl3, λmbl4, λ IXII, λ ASHII, λapii, λt10, λt11, charon4A, charon a, etc., and as plasmid vectors, pBR system, pUC system, pbluescript ii system, pGEM system, pTZ system, pCL system, pET system, etc., are available, but not limited thereto.
The above vectors may be representatively constructed as vectors for cloning or vectors for expression. The vector for expression may use a conventional vector used in the art for expressing a foreign gene or protein in a plant, animal or microorganism, and may be constructed by various methods well known in the art.
The "recombinant vector" used in the present invention may be constructed using a prokaryotic cell or a eukaryotic cell as a host. For example, when the vector used is an expression vector and prokaryotic cells are used as a host, a strong promoter (e.g., plλ promoter, CMV promoter, trp promoter, lac promoter, tac promoter, T7 promoter) that allows transcription to proceed generally contains a ribosome binding site for translation initiation and transcription/translation termination sequences. When eukaryotic cells are used as hosts, the replication origins to be initiated in eukaryotic cells contained in the vector include, but are not limited to, f1 replication origins, SV40 replication origins, pMB1 replication origins, adenovirus replication origins, AAV replication origins, BBV replication origins, and the like. In addition, promoters derived from mammalian cell genomes (e.g., metallothionein promoters) or promoters derived from mammalian viruses (e.g., adenovirus late promoter, vaccinia virus 7.5K promoter, SV40 promoter, cytomegalovirus promoter, tk promoter of HSV) may be utilized, and typically have polyadenylation sequences as transcription termination sequences.
The recombinant vector may include a selection marker for selecting transformants (host cells) transformed with the vector, and only cells expressing the selection marker may survive in the medium treated with the selection marker, thereby enabling selection of the transformed cells. The selection markers include, but are not limited to, ampicillin, kanamycin, streptomycin, and chloramphenicol, as typical examples.
By inserting the recombinant vector into a host cell, a transformant can be produced, which can be obtained by introducing the recombinant vector into an appropriate host cell. The host cell is a cell in which the above-described expression vector can be stably and continuously cloned or expressed, and any host cell known in the art can be used.
When a prokaryotic cell is transformed to produce a recombinant microorganism, a strain of Escherichia coli such as E.coli JM109、E.coli BL21、E.coli RR1、E.coli LE392、E.coli B、E.coli X 1776、E.coli W3110、E.coli XL1-Blue can be used as a host cell; a corynebacterium strain; bacillus strains such as bacillus subtilis and bacillus thuringiensis; various intestinal bacteria and strains such as Salmonella typhimurium, serratia marcescens and Pseudomonas species, etc., but are not limited thereto.
In the case of transforming eukaryotic cells for the production of recombinant microorganisms, yeasts (e.g., saccharomyces cerevisiae), insect cells, plant cells, and animal cells, for example, sp2/0, CHO K1, CHO DG44, PER.C6, W138, BHK, COS7, 293, hepG2, huh7, 3T3, RIN, MDCK cell lines, etc., can be used as host cells, but are not limited thereto.
The term "transformation" as used herein refers to a phenomenon in which a foreign DNA is introduced into a host cell to artificially cause a gene change, and the term "transformant (transformat)" refers to a host cell into which a foreign DNA is introduced and in which the expression of a target gene is stably maintained.
In the above transformation, an appropriate vector introduction technique is selected according to the host cell, so that the target gene or a recombinant vector comprising the same can be expressed in the host cell. For example, the vector introduction may be performed by electroporation (electroporation), thermal shock (heat-shock), calcium phosphate (CaPO 4) precipitation, calcium chloride (CaCl 2) precipitation, microinjection (microinjection), polyethylene glycol (PEG) method, DEAE-dextran method, cationic liposome method, lithium acetate-DMSO method, or a combination thereof, but is not limited thereto. The transformed gene may be included as long as it can be expressed in the host cell, and is not limited to insertion into the chromosome of the host cell or to being located extrachromosomally.
The above transformant includes a cell transfected, transformed or infected with the recombinant vector according to the present invention in an organism or in a test tube, and may be used as the same term as a recombinant host cell, a recombinant cell or a recombinant microorganism.
According to one embodiment of the present invention, the transformant may be an Escherichia strain or a Corynebacterium strain.
The strain of the genus Escherichia may be, but not limited to, escherichia coli (ESCHERICHIA COLI), escherichia ibutescens (ESCHERICHIA ALBERTII), escherichia blattae (ESCHERICHIA BLATTAE), escherichia fries (ESCHERICHIA FERGUSONII), escherichia hertz (ESCHERICHIA HERMANNII), or Escherichia wound (ESCHERICHIA VULNERIS).
The corynebacterium strain may be Corynebacterium glutamicum (Corynebacterium glutamicum), lactobacillus plantarum (Corynebacterium crudilactis), corynebacterium desert (Corynebacterium deserti), corynebacterium broom (Corynebacterium callunae), corynebacterium threonae (Corynebacterium suranareeae), corynebacterium oleae (Corynebacterium lubricantis), corynebacterium canal Sang Bangzhuang (Corynebacterium doosanense), corynebacterium hepaticum (Corynebacterium efficiens), corynebacterium Ubbelopsis (Corynebacterium uterequi), corynebacterium parvum (Corynebacterium stationis), corynebacterium parvum (Corynebacterium pacaense), corynebacterium mirabilis (Corynebacterium singulare), corynebacterium humicola (Corynebacterium humireducens), corynebacterium maritimum (Corynebacterium marinum), corynebacterium salt tolerance (Corynebacterium halotolerans), corynebacterium pterans (Corynebacterium spheniscorum), corynebacterium freudenreichii (Corynebacterium freiburgense), corynebacterium striatum (Corynebacterium striatum), corynebacterium canis (Corynebacterium canis), corynebacterium ammoniagenes (Corynebacterium ammoniagenes), corynebacterium renifolium (Corynebacterium renale), corynebacterium pollutes (Corynebacterium pollutisoli), corynebacterium hanensis (Corynebacterium imitans), corynebacterium reesei (Corynebacterium caspium), corynebacterium testiclae (Corynebacterium testudinoris), corynebacterium pseudolarium (Corynebacaterium pseudopelargi) or Corynebacterium flavum (Corynebacterium flavescens), but is not limited thereto.
The transformant of the present invention may be a strain comprising the Qin prophage, a variant of the protein YnfQ or a polynucleotide encoding the same, or a vector comprising the same; a strain expressing a Qin prophage, a variant of protein YnfQ, or a polynucleotide as described above; or a strain having an activity against a Qin prophage or a variant of the protein YnfQ, but is not limited thereto.
The transformant of the present invention may include other protein variants or genetic variations in addition to the Qin prophage and the variants of protein YnfQ.
According to one embodiment of the present invention, the transformant may have L-aromatic amino acid productivity.
The transformant may naturally have L-aromatic amino acid productivity or may be artificially provided with L-aromatic amino acid productivity.
According to one embodiment of the present invention, the transformant has an improved L-aromatic amino acid productivity due to the altered activity of Qin prophage or protein YnfQ.
As used herein, "increased productivity" means that the productivity of L-aromatic amino acids is increased as compared to the parent strain. The parent strain refers to a wild-type strain or a mutant strain to be mutated, and includes a subject to be mutated directly or a subject to be transformed by a recombinant vector or the like. In the present invention, the parent strain may be a wild-type escherichia strain or a corynebacterium strain, or an escherichia strain or a corynebacterium strain mutated from a wild-type strain.
The transformant according to the present invention shows an increased L-aromatic amino acid productivity as compared with a strain comprising a pre-mutated protein (parent strain) by introducing a variant of Qin prophage, protein YnfQ, whereby the activity of Qin prophage, protein YnfQ is altered. More specifically, the above transformant may increase the L-aromatic amino acid production by at least 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% as compared with the parent strain, or may increase it by 1.1-fold, 1.5-fold, 2-fold, 2.5-fold, 3-fold, 3.5-fold, 4-fold, 4.5-fold, 5-fold, 5.5-fold, 6-fold, 6.5-fold, 7-fold, 7.5-fold, 8-fold, 8.5-fold, 9-fold, 9.5-fold or 10-fold, but is not limited thereto. As an example, a transformant comprising a Qin prophage, a protein YnfQ variant as described above may have an increase in L-aromatic production of more than 5% compared to the parent strain, in particular, an increase of 5 to 50% (preferably 7 to 40%).
The composition comprising the transformant according to the present invention can be used as a composition for producing an L-aromatic amino acid.
Another aspect of the present invention provides a method for producing an L-aromatic amino acid, comprising the steps of: a step of culturing the transformant in a medium; and recovering the L-aromatic amino acid from the transformant or a medium in which the transformant is cultured.
The above-mentioned culture may be carried out according to a suitable medium and culture conditions known in the art, and the medium and culture conditions may be easily adjusted and used by those skilled in the art. Specifically, the medium may be a liquid medium, but is not limited thereto. The cultivation method may include, for example, batch cultivation (batch cultivation), continuous cultivation (continuous culture), fed-batch cultivation (fed-batch cultivation), or a combination thereof, but is not limited thereto.
According to one embodiment of the invention, the above-mentioned culture medium must meet the requirements of the particular strain in a suitable manner, and can be suitably deformed by a person skilled in the art. For the culture medium of the strain of Escherichia or the strain of Corynebacterium, reference may be made to well-known document (Manual of Methods for General Bacteriology.American Society for Bacteriology.Washington D.C.,USA,1981),, but is not limited thereto.
According to one embodiment of the present invention, the medium may contain various carbon sources, nitrogen sources and trace element components. As the carbon source which can be used, there are included sugars such as glucose, sucrose, lactose, fructose, maltose, starch, cellulose and the like and carbohydrates; oil and fat such as soybean oil, sunflower seed oil, castor seed oil, coconut oil and the like; fatty acids such as palmitic acid, stearic acid, and linoleic acid; alcohols such as glycerin and ethanol; organic acids such as acetic acid. These substances may be used alone or in the form of a mixture, but are not limited thereto. As nitrogen sources that can be used, peptone, yeast extract, broth, malt extract, corn steep liquor, soybean meal and urea or inorganic compounds, for example, ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate can be included. The nitrogen source may also be used alone or in the form of a mixture, but is not limited thereto. As the supply source of phosphorus that can be used, potassium dihydrogen phosphate or dipotassium hydrogen phosphate or corresponding sodium-containing salts may be included, but are not limited thereto. The medium may contain a metal salt such as magnesium sulfate or iron sulfate required for growth, but is not limited thereto. In addition, essential growth substances such as amino acids and vitamins may be contained. In addition, precursors suitable for the culture medium may be used. The above-mentioned medium or individual components may be added to the culture broth in batches or continuously by an appropriate means during the culture, but are not limited thereto.
According to an embodiment of the present invention, during the cultivation, a compound such as ammonium hydroxide, potassium hydroxide, ammonia, phosphoric acid, and sulfuric acid may be added to the microorganism culture solution in an appropriate manner to adjust the pH of the culture solution. In addition, during the culture, an antifoaming agent such as fatty acid polyglycol ester may be used to suppress bubble generation. Further, in order to maintain the aerobic state of the culture, oxygen or an oxygen-containing gas (e.g., air) may be injected into the culture. The temperature of the culture solution may be generally 20℃to 45℃and, for example, may be 25℃to 40 ℃. The incubation time may be continued until the desired throughput of the useful substance is obtained, for example, may be 10 to 160 hours.
According to one embodiment of the present invention, in the above-mentioned step of recovering an L-aromatic amino acid from a transformant to be cultured or a medium in which the transformant is cultured, the produced L-aromatic amino acid may be collected or recovered from the medium according to a culture method and by using a suitable method known in the art. For example, centrifugation, filtration, extraction, spraying, drying, evaporation, precipitation, crystallization, electrophoresis, fractional dissolution (e.g., ammonium sulfate precipitation), chromatography (e.g., ion exchange, affinity, hydrophobicity, and size exclusion), and the like may be used, but are not limited thereto.
According to one embodiment of the present invention, in the step of recovering an L-aromatic amino acid, the medium may be centrifuged at a low speed to remove biomass, and the obtained supernatant may be separated by ion exchange chromatography.
According to one embodiment of the present invention, the step of recovering the L-aromatic amino acid may include a step of purifying the L-aromatic amino acid.
According to one embodiment of the present invention, the L-aromatic amino acid may be 1 or more selected from the group consisting of L-tryptophan, L-phenylalanine and L-tyrosine.
The variant of Qin prophage, protein YnfQ according to the present invention alters the protein activity by substitution of one or more amino acids in the amino acid sequence constituting Qin prophage, protein YnfQ, whereby L-tryptophan, L-phenylalanine or L-tyrosine can be efficiently produced by a recombinant microorganism comprising the variant.
Drawings
FIG. 1 shows the structure of a plasmid pDSG according to an embodiment of the present invention.
FIG. 2 shows the structure of plasmid pDS9 according to an embodiment of the present invention.
Detailed Description
The present invention will be described in more detail below. However, the description is merely illustrative for the purpose of facilitating understanding of the present invention, and the scope of the present invention is not limited to such illustrative description.
Example 1 preparation of a Strain expressing variants of Qin Prophage, protein YnfQ
In order to confirm the effect of the variant (SEQ ID NO: 4) in which aspartic acid (Asp) No. 26 was replaced with valine (Val) in the amino acid sequence (SEQ ID NO: 2) of Qin prophage or protein YnfQ on the production of L-aromatic amino acids, vectors expressing the above-mentioned Qin prophage or protein YnfQ variants and strains into which the above-mentioned vectors were introduced were prepared. For gene insertion of Qin prophage, variants of protein YnfQ in the strain, plasmids pDSG and pDS9 were used and made as follows.
The above plasmid pDSG (SEQ ID NO: 23) has an origin of replication which functions only in E.coli, and has an ampicillin (ampicillin) resistance gene and a guide RNA (gRNA) expression mechanism. The above plasmid pDS9 (SEQ ID NO: 24) has an origin of replication which functions only in E.coli, has a kanamycin (kanamycin) resistance gene, a lambda Red gene (exo, bet and gam) expression system and a CAS9 expression mechanism derived from Streptococcus pyogenes (Streptococcus pyogenes).
1-1 Preparation of vector pDSG-ynfQ for transformation (Asp 26 Val)
The upstream (upstream) fragment of ynfQ was obtained for the 26 th amino acid variation in the amino acid sequence of Qin prophage, protein YnfQ by PCR using the gDNA of escherichia coli (ESCHERICHIA COLI) MG1655 (KCTC 14419 BP) as a template and the primer pair of primer 7 and primer 9 and the primer pair of primer 8 and primer 10. Then, a downstream (downstream) fragment of ynfQ of the 26 th amino acid mutation in the amino acid sequence of Qin prophage or protein YnfQ was obtained by performing PCR using the primer pair of primer 11 and primer 13 and the primer pair of primer 12 and primer 14 with escherichia coli MG1655 (KCTC 14419 BP) gDNA as a template. The upstream (upstream) and downstream (downstream) fragments contain a codon sequence for translating Asp No. 26 of the amino acid sequence of Qin prophage, protein YnfQ, into Val. Here, TAKARA PRIMESTAR Max DNA polymerase was used as a polymerase, and PCR was performed by repeating denaturation at 95℃for 10 seconds, annealing at 57℃for 15 seconds, and polymerization at 72℃for 10 seconds for 30 times.
PCR was performed using the plasmid pDSG as a template and the primer pair of primer 3 and primer 5, the primer pair of primer 4 and primer 6, the primer pair of primer 15 and primer 1, and the primer pair of primer 16 and primer 2, thereby obtaining 4 pDSG gene fragments. Each gene fragment contained a gRNA sequence targeted to Asp ynfQ. The gRNA selects the NGG pre 20mer of the sequence to be mutated. Here, TAKARA PRIMESTAR Max DNA polymerase was used as a polymerase, and PCR was performed by repeating denaturation at 95℃for 10 seconds, annealing at 57℃for 15 seconds, and polymerization at 72℃for 15 seconds 30 times.
Then, the obtained upstream (upstream) and downstream (downstream) fragments of ynfQ genes and 4 fragments of pDSG were cloned by a self-assembled cloning method (BioTechniques 51:55-56 (July 2011)), thereby obtaining a recombinant plasmid, which was named pDSG-ynfQ (Asp 26 Val).
1-2 Preparation of L-tryptophan or L-phenylalanine producing Strain into which Qin prophage, variant ynfQ of protein YnfQ (Asp 26 Val) is introduced
Coli (ESCHERICHIA COLI) KCCM13013P and KCCM10016 were used as parent strains for the production of L-tryptophan-producing strains and L-phenylalanine-producing strains, respectively.
PDS9 plasmid was transformed 1 time into each parent strain, and after culturing in LB-Km (LB liquid medium (Luria Bertani broth) containing 25g/L and kanamycin (kanamycin) containing 50 mg/L) solid medium, colonies resistant to kanamycin (kanamycin) were selected. The pDSG-ynfQ (Asp 26 Val) plasmid was transformed 2 times into the selected transformants, cultured in LB-Amp & Km (LB liquid medium (Luria Bertani broth) containing 25g/L, 100mg/L ampicillin (ampicillin) and 50mg/L kanamycin (kanamycin)) solid medium, colonies resistant to ampicillin (ampicillin) and kanamycin (kanamycin) were selected, and fragments were obtained by colony PCR using primer pairs of the music primer 17 and the primer 18. Here, TAKARA PRIMESTAR Max DNA polymerase was used as a polymerase, and PCR was performed by repeating denaturation at 95℃for 10 seconds, annealing at 57℃for 10 seconds and polymerization at 72℃for 15 seconds for 30 times. For the obtained fragment, the sequence was confirmed by sequencing of the primer pair using the primer 17 and the primer 18.
The 2 transformants were subjected to 7 subcultures in LB liquid medium, and colonies were selected in LB solid medium. Each colony was picked (picking) and cultured in LB, LB-Amp and LB-Km solid medium. Colonies that grew in LB solid medium and did not grow in LB-Amp and LB-Km solid medium were selected. The strains screened as described above were designated KCCM13013P_ ynfQ (Asp 26 Val) and KCCM10016_ ynfQ (Asp 26 Val), respectively.
The primer sequences used in example 1 are shown in Table 1 below.
[ Table 1]
Primer name | Sequence number | Primer sequence (5 '-3') |
Primer 1 | SEQ ID NO:5 | caattttattatagtaattgactattatac |
Primer 2 | SEQ ID NO:6 | TGACAGAAACcaattttattatagtaattgactattatac |
Primer 3 | SEQ ID NO:7 | GTTTCTGTCATGAATCCTTTgttttagagctagaaatagc |
Primer 4 | SEQ ID NO:8 | TGAATCCTTTgttttagagctagaaatagc |
Primer 5 | SEQ ID NO:9 | gagcctgtcggcctacctgct |
Primer 6 | SEQ ID NO:10 | cggccggcatgagcctgtcg |
Primer 7 | SEQ ID NO:11 | atgccggccgCGGACCATTCTGCCCAAGGG |
Primer 8 | SEQ ID NO:12 | CGGACCATTCTGCCCAAGGGCTAAT |
Primer 9 | SEQ ID NO:13 | AAAAGATGATGTTCTATACTGGGAAC |
Primer 10 | SEQ ID NO:14 | CAGAAACATCAAAAGATGATGTTCT |
Primer 11 | SEQ ID NO:15 | GATGTTTCTGACATGAATCCTTTCGGGGCA |
Primer 12 | SEQ ID NO:16 | ACATGAATCCTTTCGGGGCAAAATG |
Primer 13 | SEQ ID NO:17 | TCTCCGGTCAGAGATGGAAACCCTG |
Primer 14 | SEQ ID NO:18 | GACTTTATGATCTCCGGTCAGAGAT |
Primer 15 | SEQ ID NO:19 | TCATAAAGTCgagctcctgaaaatctcgataac |
Primer 16 | SEQ ID NO:20 | gagctcctgaaaatctcgataac |
Primer 17 | SEQ ID NO:21 | TCTTGAGATTTCCTTGTTGG |
Primer 18 | SEQ ID NO:22 | AGAGCCTTATTGCTGCTTCC |
Experimental example 1 evaluation of L-aromatic amino acid production ability of Strain introduced with variant of Qin prophage, protein YnfQ
The L-tryptophan or L-phenylalanine production capacity of the parent strain (KCCM 13013P and KCCM 10016) and the strain (KCCM 13013P-ynfQ (Asp 26 Val) and KCCM 10016-ynfQ (Asp 26 Val)) into which the Qin prophage, a variant of protein YnfQ, was introduced was compared.
Each strain (parent strain or variant strain) was inoculated 1% by volume to a flask containing 10m1 of the tryptophan-producing medium or phenylalanine-producing medium of Table 2, and cultured with shaking at 37℃and 200rpm for 72 hours. After the completion of the culture, the concentration of L-tryptophan or L-phenylalanine in the medium was measured by HPLC (Agilent), and the results are shown in tables 3 and 4 below, respectively.
[ Table 2]
[ Table 3]
[ Table 4]
As shown in tables 3 and 4 above, it was confirmed that the mutants KCCM13013P_ ynfQ (Asp 26 Val) and KCCM10016_ ynfQ (Asp 26 Val) into which the variants of Qin prophage and protein YnfQ had been introduced had been improved in L-tryptophan and L-phenylalanine production by 14.8% and 10.0%, respectively, compared with the parent strain, by substituting valine for aspartic acid No. 26 in the amino acid sequence of Qin prophage and protein YnfQ.
The present invention has been studied so far, focusing on its preferred embodiments. Those skilled in the art to which the invention pertains will appreciate that the invention may be practiced in modified forms without deviating from the essential characteristics of the invention. Accordingly, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the invention is indicated in the claims rather than in the foregoing description and all differences within the scope equivalent thereto are intended to be included in the present invention.
[ PREPARATION METHOD ]
Preservation agency name: korean culture collection for classical cultures (KCTC)
Deposit number: KCTC14419BP
The preservation date: 20201228
Preservation agency name: korean microorganism collection center (KCCM)
Deposit number: KCCM13013P
The preservation date: 20210622
Preservation agency name: korean microorganism collection center (KCCM)
Deposit number: KCCM10016
The preservation date: 19921024.
Claims (7)
1. A variant of Qin prophage or protein YnfQ comprising the amino acid sequence of SEQ ID No. 4 is obtained by substituting valine as Asp in the amino acid sequence of SEQ ID No. 2 with valine as Val.
2. A polynucleotide encoding the variant of claim 1.
3. A transformant comprising the variant of claim 1 or the polynucleotide of claim 2.
4. A transformant according to claim 3, wherein the transformant is an Escherichia strain or a Corynebacterium strain.
5. The transformant according to claim 3, wherein the transformant has L-aromatic amino acid productivity.
6. A method for producing an L-aromatic amino acid, comprising the steps of:
a step of culturing the transformant according to claim 3 in a medium; and
Recovering the L-aromatic amino acid from the transformant or a medium in which the transformant is cultured.
7. The method according to claim 6, wherein the L-aromatic amino acid is 1 or more selected from the group consisting of L-tryptophan, L-phenylalanine and L-tyrosine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2022-0137247 | 2022-10-24 | ||
KR10-2023-0136991 | 2023-10-13 | ||
KR1020230136991A KR20240058000A (en) | 2022-10-24 | 2023-10-13 | Novel variant of Qin prophage; protein YnfQ and method for producing L-aromatic amino acid using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117964712A true CN117964712A (en) | 2024-05-03 |
Family
ID=90854285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311384058.6A Pending CN117964712A (en) | 2022-10-24 | 2023-10-24 | Qin prophage, novel variant of protein YnfQ and method for producing L-aromatic amino acid using the same |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117964712A (en) |
-
2023
- 2023-10-24 CN CN202311384058.6A patent/CN117964712A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116606820B (en) | Novel variant of ATP synthase and method for producing L-aromatic amino acid using same | |
CN117043178A (en) | Novel variant of transport protein and method for producing L-aromatic amino acid using same | |
KR102589135B1 (en) | Microorganism having inhanced activity of 3-methyl-2-oxobutanoate hydroxymethyltransferase and uses thereof | |
CN117964712A (en) | Qin prophage, novel variant of protein YnfQ and method for producing L-aromatic amino acid using the same | |
CN117924440A (en) | Novel GlpM family protein variant and method for producing L-aromatic amino acid using same | |
CN118126142A (en) | Novel variant of H+ symporter PheP of phenylalanine and method for producing L-aromatic amino acid using the same | |
CN117925557A (en) | Novel variant of pyruvate kinase 2 and method for producing L-aromatic amino acid using same | |
CN117924441A (en) | Novel variant of DNA-binding transcription regulatory factor MalT and method for producing L-aromatic amino acid using the same | |
KR101768391B1 (en) | A microorganism having enhanced L-lysine productivity and a method of producing L-lysine using the same | |
KR101768390B1 (en) | A microorganism having enhanced L-lysine productivity and a method of producing L-lysine using the same | |
KR101760219B1 (en) | A microorganism having enhanced L-lysine productivity and a method of producing L-lysine using the same | |
CN116606823A (en) | Novel variant of zinc-binding dehydrogenase and method for producing L-aromatic amino acid using same | |
CN116940591A (en) | Sigma 38 novel variants and method for producing L-aromatic amino acids using same | |
KR102614733B1 (en) | Novel variant of phosphoenolpyruvate caboxylase and method for producing 5'-inosinic acid using the same | |
KR102434925B1 (en) | Microorganism having inhanced activity of 3-methyl-2-oxobutanoate hydroxymethyltransferase and uses thereof | |
KR20240058001A (en) | Novel variant of phenylalanine:H+ symporter PheP and method for producing L-aromatic amino acid using the same | |
CN116917469A (en) | Novel variant of stress protein and method for producing L-aromatic amino acid using same | |
KR20240058000A (en) | Novel variant of Qin prophage; protein YnfQ and method for producing L-aromatic amino acid using the same | |
KR102614734B1 (en) | Novel variant of 5-dehydro-2-deooxygluconokinase and method for producing 5'-inosinic acid using the same | |
KR102636672B1 (en) | Mutant microorganism of Corynebacterium genus producing L-glutamic acid and method for producing L-glutamic acid using the same | |
KR102546734B1 (en) | Mutant microorganism of Corynebacterium genus producing L-glutamic acid and method for producing L-glutamic acid using the same | |
KR102572849B1 (en) | Mutant microorganism of Corynebacterium genus producing L-glutamic acid and method for producing L-glutamic acid using the same | |
KR102572850B1 (en) | Mutant microorganism of Corynebacterium genus producing L-glutamic acid and method for producing L-glutamic acid using the same | |
WO2024090884A1 (en) | Novel phenylalanine:h+ symporter phep variant, and method for producing l-aromatic amino acids using same | |
WO2024090885A1 (en) | Novel variant of dna-binding transcriptional regulator malt and method for producing l-aromatic amino acid using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination |